You are here
On September 10, 2017, Project Data Sphere®, LLC, entered into a strategic collaboration with Merck KGaA to jointly lead the Global Oncology Big Data Alliance (GOBDA). The signed Memorandum of Understanding described three critical pillars of this emerging alliance:
• Growing the value of the core Project Data Sphere cancer research platform by providing additional data (in terms of more patients and more trials), as well as new types of data.
• Enabling the development and implementation of a Rare Cancer Patient Registry. This Registry will aggregate in a common platform the limited data available on the treatment of rare cancers. This will help to amplify it as a shared resource for future investigation and analysis.
• Supporting novel investigations into rare but serious adverse events associated with emerging immuno-oncology therapies.
In September, CEO Roundtable on Cancer Founder, President George H. W. Bush, welcomed His Excellency, WANG Yu, MD, PhD, as Honorary Chairman of CEO Roundtable on Cancer-China. He is the recently retired Director General of the China-CDC. Professor WANG Yu has been a longtime and leading supporter of the CEO Roundtable’s work in China, and in 2016 established the China-CDC as one of its country’s first and foremost Gold Standard accredited workplaces in 2016.
In July of this year, the CEO Roundtable and China-CDC signed a Memorandum of Understanding to further promote the Gold Standard in China and collaborate on the expansion of cancer research, as well as health promotion and cancer prevention efforts in China.
Created with support from a Robert Wood Johnson Foundation (RWJF) grant to encourage university CEO Cancer Gold Standard outreach and accreditation, the recently launched University Toolkit provides an online resource of best practices, FAQs, policy models and supporting research publications.
The Gold Standard is an employer-led health and wellness initiative designed to both acomdate and encourage employers of diverse organizations who wish to lead by example through their workplace policies and culture.The current version of our Toolkit, however, is specifically designed to address some of the challenges unique to an academic campus environments.
More than eighty executives from more than thirty companies, more than ten hospitals and NGOs and nearly twenty government officials, including His Excellency Yupeng ZHOU, Former Vice Mayor of Shanghai, President of Shanghai Services Federation; Prof. Yu WANG, Director General, China CDC and Dr. Jinglei WU, Director General, Shanghai Municipal Health and Family Planning Commission, convened in the Four Seasons Hall, of the Xijiao State Guest Hotel on April 19, 2017 for CEO Roundtable on Cancer-China IV.
Prof. ZHAO Guoping, Chief Scientist of the Shanghai Health Academy Chinese Academy of Science (CAS) co-hosted the meeting, a highlight of which was the announcement of a Memorandum of Understanding between the CAS-MPG Partner Institute for Computational Biology and the CEO Roundtable on Cancer to align respective Big Data initiatives to facilitate overall global health research.
Dr. WANG Zefeng, Director of CAS-MPG Partner Institute for Computational Biology, said of the collaboration between the CEO Roundtable and Shanghai Institutes for Biological Science, CAS, "It’s time for us to use the data we already have to make some differences in the world. Data and science changes fast nowadays and changes our ways of thinking…I believe PDS will be the future of open access data-sharing.” Following his keynote address, CEO Roundtable on Cancer Chairman, Robert A. Bradway, participated in a signing ceremony with Prof. WANG Zefeng.
The CEO Roundtable on Cancer has signed its first-ever Memorandum of Understanding with a province of China. In this, the most recent of now four Memoranda executed in China, the CEO Roundtable together with the province of Hainan; agreed to a range of wellness promoting and research advancing initiatives. These include helping hospitals in the province lead by example in becoming CEO Cancer Gold Standard accredited, promoting HPV screening and vaccinations, establishing medical resource exchanges, and enabling collaborative big data research activities through the Project Data Sphere platform.
At the 20th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO), Dr. Martin J. Murphy, CEO of the CEO Roundtable on Cancer, was presented with an Outstanding Foreign Advisor Award. Dr. Murphy was recognized for his longtime and ongoing contributions to the advancement of oncology research and treatment in China and around the globe.